Search

everythinglearnresearchcommunity

for

Search:↓

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Cepharanthine shows promise as a natural anticancer treatment.

Herbal medicine may help treat breast cancer and improve quality of life.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Repurposing existing drugs can improve cancer treatment but faces challenges.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

EMT and metabolic pathways help cancer cells resist treatment and spread.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Imuvert can prevent some chemotherapy-induced hair loss.

Eclipta prostrata has many traditional uses and health benefits, but more research is needed to understand how it works and ensure it's safe.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.